Couchoud, Charlotte
Fagnoni, Philippe
Aubin, François
Westeel, Virginie
Maurina, Tristan
Thiery-Vuillemin, Antoine
Gerard, Claire
Kroemer, Marie
Borg, Christophe
Limat, Samuel
Nerich, Virginie http://orcid.org/0000-0002-0351-6040
Article History
Received: 8 November 2019
Accepted: 17 June 2020
First Online: 16 July 2020
Compliance with ethical standards
:
: C. Couchoud, P. Fagnoni, C. Gérard, M. Kroemer and S. Limat have declared no conflicts of interest. F. Aubin is a consultant or investigator for BMS, MSD, Roche, GSK, Novartis, Amgen, and Pierre Fabre and has received support for congresses from BMS, MSD, Novartis and Roche. V. Westeel has received honoraria from Astra Zeneca, BMS, MSD and Roche. T. Maurina has received honoraria from Ipsen, Roche, Janssen and Sanofi. A. Thiery-Vuillemin has received honoraria from Pfizer, Astra Zeneca, Roche, BMS and MSD. C. Borg is an expert for Sanofi, Byer, Servier and MSD. V. Nerich has received honoraria from BMS, Pfizer, Roche, and Sanofi.
: This article does not contain any studies with human participants or animals performed by any of the authors.